| Literature DB >> 30559999 |
Stefano Dugheri1, Alessandro Bonari2, Ilenia Pompilio2, Marco Colpo3, Nicola Mucci2, Giulio Arcangeli2.
Abstract
The aim of this study is to validate an integrated air monitoring approach for assessing airborne formaldehyde (FA) in the workplace. An active sampling by silica gel impregnated with 2,4-dinitrophenylhydrazine, a passive solid phase microextraction technique using O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine as on-fiber derivatization reagent, an electrochemical direct-reading monitor, and an enzyme-based badge were evaluated and tested over a range of 0.020-5.12 ppm, using dynamically generated FA air concentrations. Simple linear regression analysis showed the four methods were suitable for evaluating airborne FA. Personal and area samplings in 12 anatomy pathology departments showed that the international occupational exposure limits in the GESTIS database were frequently exceeded. This monitoring approach would allow a fast, easy-to-use, and economical evaluation of both current work practices and eventual changes made to reduce FA vapor concentrations.Entities:
Keywords: air monitoring; chromatography; electrochemical sensor; enzyme-based badge; formaldehyde
Year: 2018 PMID: 30559999 PMCID: PMC6284158 DOI: 10.1016/j.shaw.2018.05.002
Source DB: PubMed Journal: Saf Health Work ISSN: 2093-7911
Fig. 1Dynamic calibration system. 1. ATIS Injector System. 2. Manometer for auxiliary inlet gas. 3. Inlet-gas. 4. Mixing chamber. 5. Measurement chamber: A. Formaldemeter-htV, B. Dräger-Bio-Check F (in detail: adapter), C. FFA-SPME-fiber, D. DNPH-cartridges and GilAir Plus. 6. Rotameter. 7. Syringe-pump. 8. Extractor-hood.
Performance comparison of the four methods performed in the lab settings.
| Theoretical FA atmospheres (ppm) | Active-sampling | Passive-sampling TWA PFBHA–SPME | Passive-sampling Rapid PFBHA–SPME | Electrochemical direct-reading Formaldemeter htV |
|---|---|---|---|---|
| 0.020 | 0.021 ± 0.003 | 0.018 ± 0.004 | 0.004 ± 0.005 | 0.004 ± 0.005 |
| 0.040 | 0.042 ± 0.004 | 0.032 ± 0.016 | 0.040 ± 0.016 | 0.024 ± 0.021 |
| 0.080 | 0.079 ± 0.003 | 0.056 ± 0.017 | 0.054 ± 0.017 | 0.064 ± 0.021 |
| 0.160 | 0.163 ± 0.011 | 0.178 ± 0.052 | 0.120 ± 0.042 | 0.216 ± 0.066 |
| 0.320 | 0.313 ± 0.016 | 0.332 ± 0.090 | 0.368 ± 0.095 | 0.302 ± 0.094 |
| 0.640 | 0.642 ± 0.034 | 0.644 ± 0.086 | 0.602 ± 0.091 | 0.638 ± 0.097 |
| 1.280 | 1.298 ± 0.093 | 1.322 ± 0.243 | 1.442 ± 0.288 | 1.284 ± 0.291 |
| 2.560 | 2.541 ± 0.072 | 2.776 ± 0.312 | 2.318 ± 0.421 | 2.556 ± 0.277 |
| 5.120 | 5.124 ± 0.272 | 5.424 ± 0.437 | 5.082 ± 0.372 | 5.456 ± 0.444 |
| MSE | 0.008 | 0.045 | 0.048 | 0.047 |
| β ± se | 0.997 ± 0.008 | 0.923 ± 0.015 | 0.999 ± 0.021 | 0.933 ± 0.016 |
| p value test, H0: β = 0 | <0.001 | <0.001 | <0.001 | <0.001 |
| p value test, H0: β = 1 | 0.812 | <0.001 | 0.976 | <0.001 |
| Residual MSE | 0.008 | 0.030 | 0.047 | 0.033 |
| Correlation | 0.998 | 0.994 | 0.991 | 0.994 |
| p value test, H0: ρ = 0 | <0.001 | <0.001 | <0.001 | <0.001 |
DNPH, 2,4-dinitrophenylhydrazine, FA, formaldehyde; PFBHA, O-(2,3,4,5,6-pentafluorobenzyl) hydroxylamine; MSE, mean squared error; SPME, solid phase microextraction; TWA, time-weighted average.
Fig. 2Cohen's kappa (Y axis) vs FA concentrations (X axis) scatterplot of FA enzyme-based badge visual testing. Lowest, highest and mean results from eleven selected subjects are shown vertically on the graph. Kappa = 0 is approximately equivalent to an accuracy = 0.5.
FA, formaldehyde.
Summary of FA personal sampling results determined in 12 hospitals by the four evaluated methods.
| Hospital wards | Operations | Number of operations/8 h (mean) | 15-min STEL/8-h TWA (Number of samplings) | Active-sampling | Passive-sampling | Formaldemeter | Dräger-Bio-check F | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating theater | Immersion of the biopsy in 4% FA container | |||||||||
| 1SecurBiop 60 mL (Trace, Italy) | ||||||||||
| Background | – | 4/7 | 0.02 (0.01–0.04) | 0.011 (0.006–0.026) | <0.03 (<0.03–0.03) | 0.013 (<0.01–0.029) | 0.03 | 0.01 | up to 0.05 (up to 0.05) | |
| (0.01–0.05) | ||||||||||
| Immersion of small biopsies in pre-filled 4% FA containers1,2,3,4 | 41 | 16/25 | 0.05 (0.01–0.10) | 0.016 (0.012–0.086) | 0.04 (<0.03–0.22) | 0.019 (0.011–0.101) | 0.05 | 0.03 | up to 0.05 (up to 0.05–>0.3) | |
| (0.01–0.31) | ||||||||||
| Immersion of large biopsies in 1 or 5 L 4% FA containers5 | 22 | 16/14 | 0.419 (0.01–1.36) | 0.101 (0.036–0.512) | 0.59 (<0.03–4.55) | 0.089 (<0.01–0.473) | 0.65 | 0.09 | 0.1 to 0.2 (up to 0.05–>0.3) | |
| (0.02–4.02) | ||||||||||
| Segretariat | Registration and labeling of the 4% FA containers coming from operating theater | |||||||||
| Background | – | 7/10 | 0.04 (0.03–0.08) | 0.021 (0.018–0.036) | 0.05 (<0.03–0.09) | 0.029 (0.015–0.048) | 0.06 | 0.04 | up to 0.05 (0.05–0.1) | |
| (0.01–0.06) | ||||||||||
| Registration and labeling of biopsies in pre-filled 4% FA containers1,2,3,4 | 78 | 44/42 | 0.29 (0.02–1.29) | 0.084 (0.01–0.726) | 0.21 (<0.03–3.94) | 0.077 (0.02–0.673) | 0.32 | 0.09 | up to 0.05 (up to 0.05–>0.3) | |
| (0.0–3.52) | ||||||||||
| Registration and labeling of biopsies in 1 or 5 L 4% FA containers5 | 97 | 26/47 | 0.19 (0.02–0.99) | 0.071 (0.01–0.349) | 0.18 (<0.03–3.78) | 0.055 (0.02–0.301) | 0.21 | 0.06 | up to 0.05 (up to 0.05–>0.3) | |
| (0.03–3.66) | ||||||||||
| Pathology laboratory | Cut up of previously fixed surgical pathology specimens | |||||||||
| Background | – | 8/5 | 0.04 (0.02–0.07) | 0.032 (0.019–0.041) | 0.05 (0.04–0.10) | 0.038 (0.018–0.051) | 0.05 | 0.03 | up to 0.05 (0.05–0.1) | |
| (0.01–0.06) | ||||||||||
| Cut up of previously fixed small biopsies | 61 | 31/76 | 0.201 (0.08–1.17) | 0.083 (0.046–0.501) | 0.175 (0.07–3.06) | 0.067 (0.032–0.436) | 0.229 | 0.08 | up to 0.05 (up to 0.05–>0.3) | |
| (0.03–3.48) | ||||||||||
| Cut up of previously fixed large biopsies | 82 | 36/30 | 0.385 (0.11–1.76) | 0.196 (0.066–0.897) | 0.431 (0.13–5.09) | 0.215 (0.087–1.126) | 0.311 | 0.431 | 0.1 to 0.2 (up to 0.05–>0.3) | |
| (0.19–4.77) | ||||||||||
| Sealed by UVS of the labeled bags after the reduction | 23 | 13/15 | 0.29 (0.07–0.57) | 0.099 (0.048–0.23) | 0.33 (0.05–1.84) | 0.108 (0.035–0.17) | 0.32 | 0.39 | up to 0.05 (up to 0.05–>0.3) | |
| (0.04–1.01) | ||||||||||
| Pearson correlation factor (p value) (number of determinations = 471) | Active-sampling DNPH-cartridge method | |||||||||
DNPH, 2,4-dinitrophenylhydrazine; FA, formaldehyde; FFA, fast fit assembly; PFBHA, O-(2,3,4,5,6-pentafluorobenzyl) hydroxylamine; SPME, solid phase microextraction; STEL, short-term exposure limit; TWA, time-weighted average; UVS, under-vacuum sealing.
The 15 min measurements were performed during the most critical activity for the occupational exposure.
Surgery department with a mean of eight operating theaters.
Segretariats and pathology laboratories receive specimens also from several ambulatories and regional peripheral hospitals.
Area sampling before starting work.
Fig. 3FA Data Storing System: the connection of the four analytical methods and the linking output to Bika LIMS.
DNPH, 2,4-dinitrophenylhydrazine; FA, formaldehyde; PFBHA, O-(2,3,4,5,6-pentafluorobenzyl) hydroxylamine; SPME, solid phase microextraction.